[Antibacterial protection and the microbiological status of the oral cavity in Sjögren's disease].
The microflora of the oral cavity was studied with a view to the evaluation of the microbiological status and the content of lysozyme in mixed saliva samples from 14 patients with Sjögren's syndrome and the control group of 19 persons. Disturbances in the biocenosis of the oral cavity of the patients, characterized by the increased occurrence of rod-shaped forms of lactobacilli, yeast-like fungi of the genus Candida and cariogenic streptococci (S. mutans) in the cultures obtained by the inoculation of oral smears, was detected. This "cariogenic situation" was confirmed by clinical data on the stomatological status. In patients with Sjögren's syndrome the intensity of caries, determined by the ratio of carious, filled and extracted teeth, was high and reached 27.4 +/- 1.0 in comparison with 15.3 +/- 0.7 in the control group (P less than 0.05). A decrease in the level of mixed saliva secretion and in the content of lysozyme in secreted saliva was noted in the patients in comparison with the control group (P less than 0.05). The results thus obtained indicate that in Sjögren's syndrome the use of the preparations of eubiotic microorganisms with a view to the correction of the microflora of the oral cavity, as well as the application of 0.1% lysozyme solution to the mucous membrane of the oral cavity, may be recommended among other therapeutic measures.
Pozharitskaia
M M
MM
Morozova
L V
LV
D000328:Adult; D000368:Aged; D001419:Bacteria / Q000302:isolation & purification; D002175:Candida / Q000302:isolation & purification; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009055:Mouth / Q000276:immunology* / Q000382:microbiology; D009113:Muramidase / Q000032:analysis; D012463:Saliva / Q000032:analysis; D012472:Salivation; D012636:Secretory Rate; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000276:immunology* / Q000382:microbiology
D009113:Muramidase
Antibakterial'naia zashchita i mikrobiologicheskiĭ status polosti rta pri bolezni Shegrena.